European Archives - Page 776 of 1345 - European Medical Journal

A joint mission for social justice

Social justice is a rising priority for all industries, but particularly for the pharmaceutical sector in the wake of COVID-19 and the social inequities it unveiled. We look at how the industry is increasingly working alongside the world’s top advertising agencies to promote growth from good in their activities.

How can medical affairs lead the way in neurology?

Neurological conditions are complex and require a high level of expertise and sensitivity, making them an juicy area for medical affairs teams. How do the challenges shape the MA role in this space and how is the landscape evolving?

A breakdown of pharma's reputation

This infographic tracks the evolution of the industry’s reputation by breaking down the perspectives of individual countries and generations, while also examining the impact of the COVID-19 pandemic on public outlook.

SARS-CoV-2 and Cystic Fibrosis: Expectations Versus Reality, a Literature Review

Cystic fibrosis (CF) is a chronically deteriorating lung condition that can affect multiple systems, frequently accompanied by…

An Aesthetic Alliance

In this podcast, we navigate the nuances of aesthetic surgery, explore what a holistic and patient-centric approach truly means, discuss the partnership of doctor and patient-centric approach truly means, discuss the partnership of doctor and nurse, and share their experiences of integrating work and married life.

The Benefits of Genomic Microarray in the Age of NGS

In this podcast, discover the continuing advantages of chromosomal microarray in cytogenetics. Jonathan sits down with Dr Shashi Shetty, Director of Cytogenetics Laboratory, Cleveland Medical Centre, Cleveland, Ohio, to explore at what point microarrays are the preferred choice for genetic research testing in the age of next generation sequencing (NGS).

Into the Flow #2: AKI Prevention with RenalGuard

This week’s episode is a follow-up from a previous episode published back in February called ‘Into the Flow: AKI Prevention with RenalGuard’, which centered around RenalGuard and the ability to prevent Acute Kidney Injury (AKI) through its use in percutaneous interventions.

Could Depressive Symptoms Act as a Predictor for Rapid Kidney Decline?

Frequent depressive symptoms have been linked to future rapid kidney decline in a study of adults with normal kidney function. Find out more

Does Vitamin D Supplementation Promote Kidney Function in Patients with Prediabetes?

Low vitamin D in the blood has been associated with an increased risk of various diseases including Type 2 diabetes mellitus and kidney disease.

EMJ Hematology 9 [Supplement 4] 2021 Feature Image

Emerging Insights in the Treatment of Patients with Haemophilia A

At the 14th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD), held virtually, data on the efficacy…